Article

Posterior placement of large orbital balls resolves PESS

The insertion of larger orbital balls placed more posteriorly reduced the number of subsequent procedures.

Dr. Collin presented the A.D. Ruedemann Lecture at a combined meeting of the American Society of Ocularists and the American Academy of Ophthalmology/Society of European Ophthalmologists.

Seeking to improve techniques for correction of PESS, Dr. Collin's colleagues at Moorfields began to study the backward tilt of the artificial eye and related issues such as lid retraction, the shallow lower fornix, and the pathophysiology of PESS.

In the early 1990s, based on the findings from various studies, Dr. Collin and his colleagues changed their practice and subsequently compared the outcomes of a series of PESS cases from what they termed the early years (1984 to 1993) versus the late years (1994 to 2003).

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.